Innogen · People · Innogen Associates
Professor Peter Ghazal

Chair of Molecular Genetics and Biomedicine

P.Ghazal@ed.ac.uk

+44 (0)131 242 6288

Division of Infection and Pathway Medicine
University of Edinburgh Medical School
The Chancellor’s Building
49 Little France Crescent
Edinburgh EH16 4SB

www.ed.ac.uk/schools-departments/pathway-medicine/staff-profiles/ghazal

Peter Ghazal is Professor of Molecular Genetics and Biomedicine at the University of Edinburgh. His research interests are in the field of host genomics of early-life infection, mapping gene networks of systemic host response to infection and understanding the link between sterol metabolism and immune response. These studies are specifically aimed at the development of new diagnostic and therapeutic strategies, including predictive modelling of host-defence against infection. He has active clinical investigations using systems biology in neonatal sepsis, childhood pneumonia and vaccine responses. His career spans 17 years in the USA and the last 15 years here in Edinburgh, he has published more than 200 papers and 9 patent applications.

Professor Ghazal has been a member on a number of advisory boards and committees within academia, industry, charitable and government bodies in the UK, EU, USA and Canada, and is presently Chair of the Virus Scientific Advisory Board for the Wellcome Trust Sanger Institute, and a member of the Scientific Advisory Board for the NIH Human Immunology Project Consortium in the USA. He has co-founded three biotech start-ups in Scotland, Arrayjet Ltd, Lab901 Ltd (recently acquired by Agilent Technologies Inc) and more recently, Fios Genomics Ltd.